Tumor responder analyses
tumor, TTD
DISEASE, TUMOR
An exploratory analysis using pooled data from both study arms was conducted to examine the relationship between radiologic tumor responses and HRQoL. Patients were characterized by their best overall radiologic response as responders (complete or partial response) or nonresponders (stable disease, progressive disease, or unknown/not evaluated). Time to first deterioration and time to definitive deterioration were assessed for responders versus nonresponders using similar methods as those described in the TTD section.